Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 10,130 | 12,001 | 9,505 | 6,793 | 0 |
| Cost of Goods | 6,768 | 8,711 | 6,031 | 3,579 | N/A |
| Gross Profit | 3,361 | 3,289 | 3,475 | 3,214 | N/A |
| Operating Expenses | 30,004 | 24,416 | 26,724 | 24,961 | 0 |
| Operating Income | -25,875 | -20,415 | -23,219 | -21,168 | N/A |
| Interest Expense | 2,286 | 1,381 | 591 | 470 | 0 |
| Other Income | -1,633 | 3,315 | 463 | 2,803 | 0 |
| Pre-tax Income | -29,794 | -18,481 | -23,347 | -18,836 | 0 |
| Income Tax | 21 | 16 | 19 | 13 | N/A |
| Net Income Continuous | -29,815 | -18,496 | -23,365 | -18,849 | N/A |
| Net Income | $-29,815 | $-18,496 | $-23,365 | $-18,849 | $N/A |
| EPS Basic Total Ops | -1,191.62 | -1,562.87 | -5,179.64 | -187,101.80 | N/A |
| EPS Basic Continuous Ops | -1,191.97 | -1,565.03 | -5,180.02 | -187,102.70 | N/A |
| EPS Diluted Total Ops | -1,191.62 | -1,562.87 | -5,179.64 | -187,101.80 | N/A |
| EPS Diluted Continuous Ops | -1,191.97 | -1,565.03 | -5,180.02 | -187,102.70 | N/A |
| EPS Diluted Before Non-Recurring Items | -1,137.73 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,747 | $-19,095 | $-21,715 | $-20,053 | $N/A |